PDS Biotechnology Corp
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $55.9M | $58.9M |
| Jun 2022 | — | $51.4M | $53.0M |
| Sep 2022 | — | $47.1M | $71.6M |
| Dec 2022 | — | $44.0M | $73.8M |
| Mar 2023 | — | $41.0M | $65.2M |
| Jun 2023 | — | $32.4M | $60.6M |
| Sep 2023 | — | $24.5M | $54.3M |
| Dec 2023 | — | $26.1M | $56.6M |
| Mar 2024 | — | $37.2M | $66.6M |
| Jun 2024 | — | $30.9M | $57.7M |
| Sep 2024 | — | $22.0M | $49.8M |
| Dec 2024 | — | $19.0M | $41.7M |
| Mar 2025 | — | $22.4M | $40.0M |
| Jun 2025 | — | $16.0M | $31.9M |
| Sep 2025 | — | $9.5M | $26.2M |
| Dec 2025 | — | $9.3M | $26.7M |
| Mar 2026 | — | $3.9M | $21.7M |
| Jun 2026 | — | $-3.6M | $5.6M |